Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -171,298 | 7,998 | -54,365 | -34,682 | -20,243 |
| Depreciation Amortization | -4,156 | -7,175 | -6,775 | 319 | 213 |
| Accounts receivable | -17,205 | -8,175 | N/A | N/A | N/A |
| Other Working Capital | -20,004 | -1,809 | -7,361 | -12,754 | -356 |
| Other Operating Activity | 41,797 | 22,709 | 9,235 | 7,039 | 2,825 |
| Operating Cash Flow | $-170,866 | $13,548 | $-59,266 | $-40,078 | $-17,561 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 64,967 | -98,038 | -87,005 | N/A | N/A |
| PPE Investments | -339 | -563 | -175 | -199 | -55 |
| Purchase Sale Intangibles | -7,860 | -7,500 | N/A | N/A | N/A |
| Other Investing Activity | -7,860 | -7,500 | 0 | 0 | 0 |
| Investing Cash Flow | $56,768 | $-106,101 | $-87,180 | $-199 | $-55 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 98,917 | 69,383 | N/A | N/A | N/A |
| Common Stock Issued | 5,681 | 3,016 | 6,899 | 570 | 169 |
| Other Financing Activity | 0 | 0 | 0 | 190,162 | 52,989 |
| Financing Cash Flow | $104,598 | $72,399 | $6,899 | $190,732 | $53,158 |
| Beginning Cash Position | 50,817 | 70,971 | 210,518 | 60,063 | 24,521 |
| End Cash Position | 41,317 | 50,817 | 70,971 | 210,518 | 60,063 |
| Net Cash Flow | $-9,500 | $-20,154 | $-139,547 | $150,455 | $35,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -170,866 | 13,548 | -59,266 | -40,078 | -17,561 |
| Capital Expenditure | -339 | -563 | -175 | -199 | -55 |
| Free Cash Flow | -171,205 | 12,985 | -59,441 | -40,277 | -17,616 |